Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patients:
- Adults aged 18 or older
- People who have been diagnosed with one of the following blood cancers or related conditions: high-risk myelodysplastic syndrome (MDS) or a related overlap condition, acute myeloid leukemia (AML) in people aged 80 or older, or those receiving palliative care or who have relapsed, lymphoma in people aged 80 or older, or those whose condition has come back or is not responding to treatment, or who are receiving palliative care, or multiple myeloma in people aged 80 or older, or those whose condition has come back or is not responding to treatment
- People who have limited treatment options available to them
- People who have enough Danish language skills to take part in the sessions and provide information for the study
- People who have given their informed consent to participate
Informal caregivers (identified by the patient):
- Adults aged 18 or older who the patient has identified as their main source of informal physical, practical, or emotional support
- People who are able to accompany the patient to their appointments as part of the trial
- People who have enough Danish language skills to take part in the sessions and provide information for the study
- People who have given their informed consent to participate
Doctors and nurses:
- Hematology specialists treating patients with one of the listed blood conditions, who work at the same department for the entire duration of the trial
- Nurses treating patients with one of the listed blood conditions, who work at the same department for the entire duration of the trial
Who may not be able to join:
- Patients or caregivers where either person has a severe psychiatric disorder
- Doctors or nurses who do not meet the inclusion criteria listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christoffer Johansen, Professor, Rigshospitalet, Denmark
Phone: +45 60701620
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Use of chemotherapy within the last 30 days of life.; Change from baseline through 3,6,9,12 and 18 months follow-up in patient's anxiety symptoms; Change from baseline through 3,6,9,12 and 18 months follow-up in caregiver's anxiety symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.